May. 23 at 2:39 AM
$CERS is sitting directly on a critical macro breakout retest at
$2.40 following a massive institutional volume wave 🌊
Cerus Corp. A pure-play leader in global pathogen-reduction blood technology. The fundamental story completely matches the chart now—blowout Q1 earnings, surging product demand, and a fresh 4-year national supply deal. The weekly chart shows a clean flag pattern resting right on top of its key moving averages.
🐂 Bulls want to see this
$2.40 floor hold to fuel a secondary mean-reversion squeeze past
$3.15 resistance, targeting the
$4.00 psychological wall.
🐻 Bears want to break this support cluster, forcing a deeper retracement back to the
$1.80 macro demand base.
📊 Lean: BULLISH. The underlying business turnaround is accelerating, and the options flow is heavily stacked in out-of-the-money calls. Watch the
$2.40 hold closely.
#CERS #Biotech #OptionsFlow #hovdid
